The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Hallucinations


Psychiatry related information on Hallucinations


High impact information on Hallucinations


Chemical compound and disease context of Hallucinations


Biological context of Hallucinations


Anatomical context of Hallucinations


Gene context of Hallucinations


Analytical, diagnostic and therapeutic context of Hallucinations


  1. Syncope and visual hallucinations, apparently from timolol. Yates, D. JAMA (1980) [Pubmed]
  2. Central nervous system reactions to histamine-2 receptor blockers. Cantú, T.G., Korek, J.S. Ann. Intern. Med. (1991) [Pubmed]
  3. Naloxone does not benefit levodopa-induced hallucinations in Parkinson's disease. Sandyk, R., Gillman, M.A. Ann. Neurol. (1984) [Pubmed]
  4. The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity. O'Hearn, E., Molliver, M.E. J. Neurosci. (1997) [Pubmed]
  5. Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada clinical trials group study. Khoo, K., Brandes, L., Reyno, L., Arnold, A., Dent, S., Vandenberg, T., Lebwohl, D., Fisher, B., Eisenhauer, E. J. Clin. Oncol. (1999) [Pubmed]
  6. Phencyclidine poisoning. Tong, T.G., Benowitz, N.L., Becker, C.E., Forni, P.J., Boerner, U. JAMA (1975) [Pubmed]
  7. Genetic studies in the sleep disorder narcolepsy. Kadotani, H., Faraco, J., Mignot, E. Genome Res. (1998) [Pubmed]
  8. Complex visual hallucinations. Clinical and neurobiological insights. Manford, M., Andermann, F. Brain (1998) [Pubmed]
  9. Anatomical origin of déjà vu and vivid 'memories' in human temporal lobe epilepsy. Bancaud, J., Brunet-Bourgin, F., Chauvel, P., Halgren, E. Brain (1994) [Pubmed]
  10. Cerestat and other NMDA antagonists in ischemic stroke. Lees, K.R. Neurology (1997) [Pubmed]
  11. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. Lowance, D., Neumayer, H.H., Legendre, C.M., Squifflet, J.P., Kovarik, J., Brennan, P.J., Norman, D., Mendez, R., Keating, M.R., Coggon, G.L., Crisp, A., Lee, I.C. N. Engl. J. Med. (1999) [Pubmed]
  12. Erythropoietin and visual hallucinations. Steinberg, H. N. Engl. J. Med. (1991) [Pubmed]
  13. Cimetidine and visual hallucinations. Agarwal, S.K. JAMA (1978) [Pubmed]
  14. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., Spiegel, R. Lancet (2000) [Pubmed]
  15. Unusual opioid withdrawal syndrome. A case-report. Kumor, K.M., Grochow, L.B., Hausheer, F. Lancet (1987) [Pubmed]
  16. Hallucinations after withdrawal of baclofen. Lees, A.J., Clarke, C.R., Harrison, M.J. Lancet (1977) [Pubmed]
  17. Hallucination during sustained-release morphine and methadone administration. Jellema, J.G. Lancet (1987) [Pubmed]
  18. Hallucinations in a child after drinking triprolidine/pseudoephedrine linctus. Ackland, F.M. Lancet (1984) [Pubmed]
  19. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study. Goldsmith, S.K., Shapiro, R.M., Joyce, J.N. Arch. Gen. Psychiatry (1997) [Pubmed]
  20. Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Janowsky, D.S., Davis, J.M. Arch. Gen. Psychiatry (1976) [Pubmed]
  21. Complex visual hallucinations and cyclosporine. Noll, R.B., Kulkarni, R. Arch. Neurol. (1984) [Pubmed]
  22. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Borg, S., Czarnecka, A., Kvande, H., Mossberg, D., Sedvall, G. Alcohol. Clin. Exp. Res. (1983) [Pubmed]
  23. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia. Engelborghs, S., Vloeberghs, E., Maertens, K., Mariën, P., Somers, N., Symons, A., Clement, F., Ketels, V., Saerens, J., Goeman, J., Pickut, B.A., Vandevivere, J., De Deyn, P.P. International journal of geriatric psychiatry. (2004) [Pubmed]
  24. Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium. Sander, T., Harms, H., Rommelspacher, H., Hoehe, M., Schmidt, L.G. Psychiatr. Genet. (1998) [Pubmed]
  25. Association between FOXP2 polymorphisms and schizophrenia with auditory hallucinations. Sanjuán, J., Tolosa, A., González, J.C., Aguilar, E.J., Pérez-Tur, J., Nájera, C., Moltó, M.D., de Frutos, R. Psychiatr. Genet. (2006) [Pubmed]
  26. Localizing value of epileptic visual auras. Bien, C.G., Benninger, F.O., Urbach, H., Schramm, J., Kurthen, M., Elger, C.E. Brain (2000) [Pubmed]
  27. Musical hallucinations associated with post-thyroidectomy hypoparathyroidism and symmetric basal ganglia calcifications. Wodarz, N., Becker, T., Deckert, J. J. Neurol. Neurosurg. Psychiatr. (1995) [Pubmed]
  28. Cortical activity associated with auditory hallucinations. Ropohl, A., Sperling, W., Elstner, S., Tomandl, B., Reulbach, U., Kaltenhäuser, M., Kornhuber, J., Maihöfner, C. Neuroreport (2004) [Pubmed]
  29. Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder? Baumann, C., Ferini-Strambi, L., Waldvogel, D., Werth, E., Bassetti, C.L. J. Neurol. (2005) [Pubmed]
  30. Alcohol, the cerebral circulation and strokes. Altura, B.M., Altura, B.T. Alcohol (1984) [Pubmed]
  31. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Goetz, C.G., Burke, P.F., Leurgans, S., Berry-Kravis, E., Blasucci, L.M., Raman, R., Zhou, L. Arch. Neurol. (2001) [Pubmed]
  32. Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism. Okubo, T., Harada, S., Higuchi, S., Matsushita, S. Alcohol. Clin. Exp. Res. (2002) [Pubmed]
  33. The serotonin-2A receptor polymorphism and smoking behavior in Japan. Terayama, H., Itoh, M., Fukunishi, I., Iwahashi, K. Psychiatr. Genet. (2004) [Pubmed]
  34. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Makoff, A.J., Graham, J.M., Arranz, M.J., Forsyth, J., Li, T., Aitchison, K.J., Shaikh, S., Grünewald, R.A. Pharmacogenetics (2000) [Pubmed]
  35. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. Holmes, C., Smith, H., Ganderton, R., Arranz, M., Collier, D., Powell, J., Lovestone, S. J. Neurol. Neurosurg. Psychiatr. (2001) [Pubmed]
  36. Ketamine and postoperative pain--a quantitative systematic review of randomised trials. Elia, N., Tramèr, M.R. Pain (2005) [Pubmed]
  37. Clarithromycin-associated visual hallucinations in a patient with chronic renal failure on continuous ambulatory peritoneal dialysis. Steinman, M.A., Steinman, T.I. Am. J. Kidney Dis. (1996) [Pubmed]
  38. Effect of the benzodiazepine derivative estazolam in patients with auditory hallucinations. A multicentre double-blind, cross-over study. Lingjaerde, O. Acta psychiatrica Scandinavica. (1982) [Pubmed]
  39. Restless legs syndrome probably induced by risperidone treatment. Wetter, T.C., Brunner, J., Bronisch, T. Pharmacopsychiatry (2002) [Pubmed]
  40. Focal ischemia enhances the adverse effect potential of N-methyl-D-aspartate receptor antagonists in rats. Löscher, W., Wlaź, P., Szabo, L. Neurosci. Lett. (1998) [Pubmed]
WikiGenes - Universities